Senolytic drug combo boosts cancer immunotherapy and reduces side effects
Researchers have discovered that targeting immune cell ageing can overcome resistance to head and neck cancer treatment.
List view / Grid view
Researchers have discovered that targeting immune cell ageing can overcome resistance to head and neck cancer treatment.
New research from Harvard Medical School shows that natural lithium deficiency in the brain may be a key early factor driving Alzheimer’s disease – which allow for the development of new approaches to preventing and reversing cognitive decline.
Researchers have developed a new AI tool which recognises that protein behaviour can vary by cell and by tissue type.
In animal studies, the new vaccine construct outperformed another PNAG-vaccine delivery system currently in human trials.
A certain macrophage phenotype is more effective than another phenotype commonly used in cell therapy for infiltrating tumours.
Midbody’s role in cell signalling and stimulating cell proliferation offers an opportunity to detect cancer.
Boosting the body’s anti-viral immune response could restore tissue balance and eliminate ageing cells that contribute to age-related diseases.
The scientists used a new in vitro platform, which allowed intestinal organoids to be cultured on an open lumen, planar system that could be manipulated experimentally.
By creating a drug that is based on part of the SARS-CoV-2 spike protein, US and Finnish researchers can block the virus from entering cells.
Using cryo-EM, the researchers found that the B-cell receptor interacts with further receptors, thus controlling its signal transduction.
Researchers have been able to significantly reduce tumours in a pre-clinical model of a rare genetic lung disease.
Using chemical genetic screening and pre-clinical model studies, researchers have discovered that inducing ubiquitin-mediated degradation of mutant EZH2 could provide a more effective treatment strategy for haematologic malignancies.
The La Jolla Institute for Immunology and Brigham and Women's Hospital will collaborate to develop a pan-coronavirus vaccine.
Delivering Txnip to mice with retinitis pigmentosa was an effective treatment, making this approach a potential gene therapy for the disease.
A study has used artificial intelligence to reveal adeno-associated virus (AAV) capsid variants for use in gene therapies.